Physiological regulation of blood pressure and kidney function by guanylyl cyclase isoforms

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 1, 1997, Pages 58-63

  Kishimoto, Ichiro ^a   Garbers, David L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE; NATRIURETIC FACTOR;

BLOOD PRESSURE REGULATION; HUMAN; KIDNEY FUNCTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLOOD PRESSURE; GUANYLATE CYCLASE; HUMANS; ISOENZYMES; KIDNEY;

EID: 0031045997     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199701000-00011     Document Type: Review

References (46)

1. Garbers DL: Guanylyl cyclase receptors and their endocrine paracrine and autocrine ligands. Cell 1992, 71:1-4.
2. Garbers DL, Lowe DG: Guanylyl cyclase receptors. J Biol Chem 1994, 269:30741-30744.
3. Wilson EM, Chinkers M: Identification of sequences mediating guanylyl cyclase dimerization. Biochemistry 1995, 34:4696-4701.
4. Wedel B, Harteneck C, Foerster J, Friebe A, Schultz G, Koesling D: Functional domains of soluble guanylyl cyclase. J Biol Chem 1995, 270:24871-24875.
5. Garbers DL, Koesling D, Schultz G: Guanylyl cyclase receptors. Mol Biol Cell 1994, 5:1-5.
6. Vaandrager AB, van der Wiel E, Hom HL, Luthjens LH, de Jonge HR: Heat-stable enterotoxin receptor/guanylyl cyclase C is an oligomer consisting of functionally distinct subunits, which are non-covalently linked in the intestine. J Biol Chem 1994, 269:16409-16415.
7. Harteneck C, Wedel B, Koesling D, Malkewitz J, Böhme E, Schultz G: Molecular cloning and expression of a new α-subunit of soluble guanylyl cyclase. Interchangeability of the α-subunits of the enzyme. FEBS Letts 1991, 292:217-222.
8. Kojima M, Hisaki K, Matsuo H, Kangawa K: A new type soluble guanylyl cyclase, which contains a kinase-like domain: its structure and expression. Biochem Biophys Res Commun 1995, 217:993-1000.
9. Wilcox JH, Augustine A, Goeddel DV, Lowe DG: Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol 1991, 11:3454-3462.
10. Ritter D, Dean AD, Gluck SL, Greenwald JE: Natriuretic peptide receptors A and B have different cellular distribution in rat kidney. Kid Int 1995, 48:1758-1766.
11. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F: PCR localization of C-type natriuretic peptide and B-type receptor mRNAs in rat nephrone segments. Am J Physiol 1994, 267:F215-222.
12. Ujiie K, Drewett JG, Yuen PT, Star RA: Differential expression of mRNA for guanylyl cyclase-linked endothelium-derived relaxing factor subunits in rat kidney. J Clin Invest 1993, 91:730-734.
13. Forte LR, Krause WJ, Freeman RH: Receptors and cGMP signaling mechanism for E. Coli enterotoxin in opossum kidney. Am J Physiol 1988, 255:F1040-1046.
14. Lin X, Hanze J, Heese F, Sodmann R, Lang R: Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 1995, 77:750-758.
15. Nakane M, Saheki S, Kuno T, Ishii K, Murad F: Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem Biophys Res Commun 1988, 157:1139-1147.
16. Nakane M, Arai K, Saheki S, Kuno T, Buechler W, Murad F: Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 1990, 265:16841-16845.
17. Ikeda T, Itoh H, Komatsu Y, Hanyu M, Yoshimasa T, Matsuda K, Nakao K, Ban T: Natriuretic peptide receptors in human artery and vein and rabbit vein graft. Hypertension 1996, 27:833-837.
18. Papapetropoulos A, Cziraki A, Rubin JW, Stone CD, Catravas JD: cGMP accumulation and gene expression of soluble guanylyl cyclase in human vascular tissue. J Cell Physiol 1996, 167:213-221.
19. Chen YM, Wu KD, Hung KY, Pu YS, Hsieh BS: Quantitative analysis of messenger ribonucleic acid encoding natriuretic peptide receptors in aldosterone-producing adenoma. Mol Cell Endocrinol 1995, 111:139-146.
20. Schmidt HHW, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F: Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, a novel paraneural functions for nitrinergic signal transduction. J Histochem Biochem 1992, 40:1439-1456.
21. Giuili G, Luzi A, Poyard M, Guellaen G: Expression of mouse brain soluble guanylyl cyclase and NO synthase during ontogeny. Dev Brain Res 1994, 81:269-283.
22. Imura H, Nakao K, Itoh H: The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroenocrine functions. Frontiers Neuroendocrinol 1992, 13:217-249.
23. Lewicki JA, Protter AA: Physiological studies of the natriuretic peptide family. In Hypertension: Pathophysiology, Diagnosis, and Managment, 2nd edn. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995.
24. Reid I: Role of nitric oxide in the regulation of renin and vasopressin secretion. Frontiers Neuroendocrinol 1994, 15:351-383.
25. Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, Matsuda Y: Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun 1991, 176:949-957.
26. Ohyama Y, Miyamoto K, Morishita Y, Matsuda Y, Kojima M, Minamino N, Kangawa K, Matsuo H: HS-142-1, a novel non-peptide antagonist for natriuretic peptides, has no effect on the third members of membrane bound guanylate cyclases (GC-C) in T84 cells. Life Sci 1993, 52:PL153-PL157.
27. Zhang PL, Jimenez W, Mackenzie HS, Guo J, Troy JL, Ros J, Angeli P, Arroyo V, Brenner BM: HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo. J Am Soc Nephrol 1994, 5:1099-1105.
28. Mayer B, Brunner F, Schmidt K: Novel actions of methylene blue. Eur Heart J 1993, 14(suppl I):22-26.
29. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B: Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 1995, 48:184-188.
30. Brunner F, Schmidt K, Nielsen EB, Mayer B: Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exper Therap 1996, 277:48-53.
31. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moncada S: cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A 1996, 93:1480-1485.
32. Boulton CL, Southam E, Garthwaite J: Nitric oxide-dependent long term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 1995, 69:699-703.
33. Foster DC, Garbers DL, Wedel BJ: The guanylyl cyclase-A receptor. In Contemporary endocrinology. Edited by Conn PM, The Humana Press Inc: in press.
34. Yuen PST, Doolittle LK, Garbers DL: Dominant negative mutants of nitric oxide-sensitive guanylyl cyclase. J Biol Chem 1994, 269:791-793.
35. Maack T: Receptors of atrial natriuretic factor. Ann Rev Physiol 1992, 54:11-27.
36. John SWM, Krege JH, Oliver TM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O: Genetic decrease in atrial natriuretic peptide and salt-sensitive hypertension [published erratum appears in Science 1995, 267:1753]. Science 1995, 267:679-681. The ANP gene is disrupted in this work. When ANP-deficient mice were fed high salt (8%) diets, the blood pressures were elevated relative to standard diets, and it was, therefore, suggested that ANP was critical for the handling of dietary sodium by the kidney.
37. John SWM, Veress AT, Honrath U, Chong CK, Peng L, Smithies O, Sonnenberg H: Blood pressure and fluid electrolyte balance in mice with reduced or absent ANP. Am J Phsiol 1996, 40:R109-114. This is a second report on the ANP deficient mice. In this paper, anesthetized ANP null mice demonstrated a high blood pressure not affected by dietary salt. There also was no difference between urine flow and sodium excretion in ANP deficient mice and that of wild type mice. The authors concluded that ANP was not essential for chronic regulation of salt balance.
38. Lopez MJ, Wong SKF, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A: Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 1995, 378:65-68. The disruption of the GC-A gene results in chronic elevations of blood pressure which are not affected by high (8%) or low (0.008%) dietary salt. These results suggested that GC-A played a critical role in the chronic regulation of blood pressure but that the receptor was not required for the chronic regulation of salt balance.
39. Kishimoto I, Dubois S, and Garbers DL: The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci U S A 1996, 93:6215-6219. In anesthetized GC-A deficient mice, the expansion of plasma volume by intravenous infusion caused release of atrial granules but natriuresis or diuresis was impaired. These studies suggested that GC-A is a pivotal kidney receptor for natriuretic or diuretic factors, or both, released from the heart.
40. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242. In this study where the eNOS gene was disrupted, acetylcholine-induced relaxation of aortic rings was absent in eNOS deficient mice. The blood pressure of these mice are higher than those of wild type. The results suggest a major role for the soluble guanylyl cyclase in chronic and acute blood pressure regulation.
41. Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990, 168:863-870.
42. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991, 252:120-123.
43. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura H: Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, C-type natriuretic peptide. Endocrinology 1992, 130:229-239.
44. Hama N, Itoh H, Shirakami G, Suga S, Komatsu Y, Yoshimasa T, Tanaka I, Nakao K: Detection of C-type natriuretic peptide in human circulation and marked increase of CNP level in septic shock patients. Biochem Biophys Res Commun 1994, 198:1177-1182.
45. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H: Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of 'vascular natriuretic peptide system'. J Clin Invest 1993, 90:1145-1149.
46. Drewett JG, Fendly BM, Garbers DL, Lowe DG: Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta. J Biol Chem 1995, 270:4668-4674.